The tests combine the company's second-generation proteomic ovarian cancer test OVA2 with patient ultrasound results and symptom data.
Researchers from the Public Health Agency of Sweden have developed an approach for typing Clostridium difficile isolates based on their patterns of high-molecular weight proteins.
Through unbiased and targeted metabolite testing on urine samples from thousands of individuals in the US and the UK, researchers have narrowed in on urine compounds that coincide with body mass index.
A spin-out ofStanfordUniversity, Carmenta is focused on developing a test for preeclampsia, a hypertensive disorder of pregnancy.
A spin-out of Stanford University, Carmenta is focused on developing a test for preeclampsia, a hypertensive disorder of pregnancy.
In Science this week: factors influencing retrotransposon integration sites, and more.
A bioethicist argues for the responsible use of germline gene editing.
Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.
Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.